Body
![](/IQedit/Images/Company%20Logos/ABPI.gif)
“These figures seem to confirm that there is cause for concern,” says Richard Barker, ABPI director general. “While the dip is small—and, of course, is only over six months rather than the full year—it sounds another warning signal.”
Pharmaceutical manufacturers are finding that the U.K.’s business climate is less favorable to them than in the past. Other countries offer incentives for local drug manufacturers, reports the ABPI.
“We are therefore engaging with the government about how best to retain the British pharmaceuticals manufacturing base, which has contributed so strongly to our balance of trade and levels of skilled employment,” says Barker.
…
Want to continue?
Log in or create a FREE account.
By logging in you agree to receive communication from Quality Digest.
Privacy Policy.
Add new comment